PepGen (PEPG) Current Leases (2022 - 2026)
PepGen (PEPG) reported Current Leases of $3.2 million for Q1 2026, up 2.98% on a YoY basis from $3.1 million in Q1 2025, and up 0.72% sequentially from $3.2 million in Q4 2025.
PepGen (PEPG) Current Leases (2022 - 2026) Analysis & Trends
PepGen (PEPG) has 5 years of Current Leases data on file, last reported at $3.2 million in Q1 2026.
- For the quarter ending Q1 2026, Current Leases rose 2.98% year-over-year to $3.2 million; the trailing twelve-month figure through Mar 2026 stood at $3.2 million (up 2.98% YoY), and the FY2025 full-year result was $3.2 million, up 3.01% from the prior year.
- Current Leases grew to $3.2 million in Q1 2026, from $3.2 million in the prior quarter.
- In the past five years, Current Leases ranged from a high of $5.6 million in Q4 2022 to a low of $3.0 million in Q3 2023.
- A 5-year average of $3.3 million and a median of $3.1 million in 2025 frame the typical range for Current Leases.
- Across the five-year window, Current Leases plunged 45.9% in 2023 and rose 3.01% in 2025, its largest moves.
- Tracing PEPG's Current Leases over 5 years: stood at $5.6 million in 2022, then sank by 45.9% to $3.0 million in 2023, then rose by 3.0% to $3.1 million in 2024, then climbed by 3.01% to $3.2 million in 2025, then climbed by 0.72% to $3.2 million in 2026.
- Business Quant data shows PEPG's Current Leases at $3.2 million in Q1 2026, $3.2 million in Q4 2025, and $3.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 531,233.95 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 20.58 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 872,589.03 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 720.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 11.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.61 Mn |
| 10 | PepGen | 145.09 Mn | 145.09 Mn | - | 3.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.21 Mn |
| Dec 31, 2025 | 3.19 Mn |
| Sep 30, 2025 | 3.16 Mn |
| Jun 30, 2025 | 3.14 Mn |
| Mar 31, 2025 | 3.12 Mn |
| Dec 31, 2024 | 3.09 Mn |
| Sep 30, 2024 | 3.07 Mn |
| Jun 30, 2024 | 3.05 Mn |
| Mar 31, 2024 | 3.03 Mn |
| Dec 31, 2023 | 3.00 Mn |
| Sep 30, 2023 | 2.98 Mn |
| Jun 30, 2023 | 3.49 Mn |
| Mar 31, 2023 | 3.66 Mn |
| Dec 31, 2022 | 5.55 Mn |